AXL and hepatocellular carcinoma: In summary, we observed that the ErbB receptor family, especially ErbB4, is co-upregulated with Gas6/Axl in Rego-resistant HCC cells indicating an Axl/ErbB receptor-mediated therapy escape (Figure 7).